Open Access

Anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis in vitro and in vivo

  • Authors:
    • Lu Che
    • Ya Li
    • Ruifeng Song
    • Cuihong Qin
    • Weiwei Hao
    • Bingxue Wang
    • Lei Yang
    • Puji Peng
    • Feng Xu
  • View Affiliations

  • Published online on: July 5, 2019     https://doi.org/10.3892/etm.2019.7736
  • Pages: 1745-1751
  • Copyright: © Che et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ulcerative colitis is closely associated with colorectal cancer, the long‑standing chronic inflammation being the key etiology of ulcerative colitis. The aim of the present study was to identify the anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis. MTT assay was used to obtain the optimal concentrations of lipopolysaccharide (LPS) and taraxasterol for cell treatments in vitro. A mouse model of colitis was established via dextran sodium sulphate (DSS) administration. Levels of IL‑6 and TNF‑α were detected through ELISA. Flow cytometry and western blotting were used to detect apoptosis and related protein expression levels, respectively. Hematoxylin and eosin staining was performed to detect the pathological damage. The results from the MTT assay identified the optimal concentration of LPS and taraxasterol, and ELISA results demonstrated that taraxasterol treatment decreased the expression levels of IL‑6 and TNF‑α in vitro and in vivo, in a dose‑dependent manner. Taraxasterol treatment inhibited apoptosis, and reduced the protein levels of p53, Bcl‑2 associated X (BAX) and caspase‑3. Finally, pathological damages were reduced in colonic tissues of mice treated with taraxasterol. Taken together, taraxasterol treatment markedly inhibited inflammation and apoptosis in ulcerative colitis. Therefore, taraxasterol may be a promising agent for decreasing the inflammatory response in ulcerative colitis and other inflammation‑related diseases.

References

1 

Scarpa M, Castagliuolo I, Castoro C, Pozza A, Scarpa M, Kotsafti A and Angriman I: Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis. World J Gastroenterol. 20:6774–6785. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Hisamatsu T, Kanai T, Mikami Y, Yoneno K, Matsuoka K and Hibi T: Immune aspects of the pathogenesis of inflammatory bowel disease. Pharmacol Ther. 137:283–297. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Rosenberg L, Nanda KS, Zenlea T, Gifford A, Lawlor GO, Falchuk KR, Wolf JL, Cheifetz AS, Goldsmith JD and Moss AC: Histologic markers of inflammation in patients with ulcerative colitis in clinical remission. Clin Gastroenterol Hepatol. 11:991–996. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Mankowska-Wierzbicka D, Swora-Cwynar E, Poniedzialek B, Adamski Z, Dobrowolska A and Karczewski J: Usefulness of selected laboratory markers in ulcerative colitis. Eur Cytokine Netw. 26:26–37. 2015.PubMed/NCBI

5 

Wei C, Tan CK, Xiaoping H and Junqiang J: Acanthoic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts. Inflammation. 38:896–901. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Kitajima S, Takuma S and Morimoto M: Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim. 48:137–143. 1999. View Article : Google Scholar : PubMed/NCBI

7 

Herz W and Mirrington RN: Identification of pyrethrol with taraxasterol. J Pharm Sci. 55:1041966. View Article : Google Scholar : PubMed/NCBI

8 

Piao T, Ma Z, Li X and Liu J: Taraxasterol inhibits IL-1β-induced inflammatory response in human osteoarthritic chondrocytes. Eur J Pharmacol. 756:38–42. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Cooper HS, Murthy SN, Shah RS and Sedergran DJ: Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 69:238–249. 1993.PubMed/NCBI

10 

Kinoshita T, Imamura R, Kushiyama H and Suda T: NLRP3 mediates NF-κB activation and cytokine induction in microbially induced and sterile inflammation. PLoS One. 10:e01191792015. View Article : Google Scholar : PubMed/NCBI

11 

Frost RA, Nystrom GJ and Lang CH: Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 283:R698–R709. 2002. View Article : Google Scholar : PubMed/NCBI

12 

Liverani E, Rico MC, Yaratha L, Tsygankov AY, Kilpatrick LE and Kunapuli SP: LPS-induced systemic inflammation is more severe in P2Y12 null mice. J Leukoc Biol. 95:313–323. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Popa C, Netea MG, van Riel PL, van der Meer JW and Stalenhoef AF: The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res. 48:751–762. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Gupta RA, Motiwala MN, Mahajan UN and Sabre SG: Protective effect of Sesbania grandiflora on acetic acid induced ulcerative colitis in mice by inhibition of TNF-α and IL-6. J Ethnopharmacol. 219:222–232. 2018. View Article : Google Scholar : PubMed/NCBI

15 

Mochizuki D, Adams A, Warner KA, Zhang Z, Pearson AT, Misawa K, McLean SA, Wolf GT and Nör JE: Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma. Oncotarget. 6:22822–22835. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Edelblum KL, Yan F, Yamaoka T and Polk DB: Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis. 12:413–424. 2006. View Article : Google Scholar : PubMed/NCBI

17 

Di Sabatino A, Ciccocioppo R, Luinetti O, Ricevuti L, Morera R, Cifone MG, Solcia E and Corazza GR: Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum. 46:1498–1507. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Al-Assaf AH, Alqahtani AM, Alshatwi AA, Syed NA, Shafi G and Hasan TN: Mechanism of cadmium induced apoptosis in human peripheral blood lymphocytes: The role of p53, Fas and Caspase-3. Environ Toxicol Pharmacol. 36:1033–1039. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Che, L., Li, Y., Song, R., Qin, C., Hao, W., Wang, B. ... Xu, F. (2019). Anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis in vitro and in vivo. Experimental and Therapeutic Medicine, 18, 1745-1751. https://doi.org/10.3892/etm.2019.7736
MLA
Che, L., Li, Y., Song, R., Qin, C., Hao, W., Wang, B., Yang, L., Peng, P., Xu, F."Anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis in vitro and in vivo". Experimental and Therapeutic Medicine 18.3 (2019): 1745-1751.
Chicago
Che, L., Li, Y., Song, R., Qin, C., Hao, W., Wang, B., Yang, L., Peng, P., Xu, F."Anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis in vitro and in vivo". Experimental and Therapeutic Medicine 18, no. 3 (2019): 1745-1751. https://doi.org/10.3892/etm.2019.7736